Skip navigation

Calls to Action

21st Century Cures

December 14, 2016

President Barack Obama on Tuesday signed the landmark biomedical innovations bill known as the 21st Century Cures Act to increase funding of the National Institutes of Health, modernize clinical trials and accelerate the rate of innovations, including the development of personalized and precision medicines that could benefit people with autism.

More...
December 07, 2016

The U.S. Senate passed biomedical innovations legislation known as the 21st Century Cures Act by a vote of 94-5. The legislation outlines provisions to increase funding of the National Institutes of Health, modernize clinical trials, and accelerate the rate of innovations, including the development of personalized and precision medicines.

More...
December 02, 2016

The U.S. House of Representatives has overwhelmingly passed biomedical innovations legislation known as the 21st Century Cures Act by a vote of 392-26.

More...
July 10, 2015

Today the house voted overwhelmingly to approve H.R. 6, better known as the 21st Century Cures Act, to accelerate the rate of medical innovations with a vote of 344-77.

More...
June 30, 2015

Washington, DC-- After the 2015 Autism Speaks Leadership Summit in Washington, DC, newly trained advocates from across the country met with their elected officials on Capitol Hill to ask for support of H.R. 6, better known as the 21st Century Cures Act, to accelerate the rate of medical innovations.

More...
June 16, 2015

Leaders in government, science and industry spur policy and research that improve lives at Autism Speaks 2015 National Summit

More...
June 01, 2015

The 21st Century Cures initiative was launched by Energy and Commerce Committee Chairman Fred Upton (R-MI) and Representative Diana DeGette (D-CO) to accelerate the rate of innovation and research in medicine. American scientists and researchers lead the world, but thousands of diseases and disorders lack effective treatments.

More...
May 21, 2015

The nonpartisan 21st Century Cures Act was unanimously approved today by the full Energy and Commerce Committee 51-0. The legislation outlines provisions to increase funding of the National Institutes of Health, modernize clinical trials, and accelerate the rate of innovations including the development of personalized and precision medicines.

More...